Literature DB >> 15229217

Role of NFAT proteins in IL13 gene transcription in mast cells.

Silvia Monticelli1, Deborah C Solymar, Anjana Rao.   

Abstract

Th2 and mast cells are participants in the asthmatic response to allergens, and both cell types produce the cytokines interleukin (IL)-4 and IL-13. IL-13 in particular is both necessary and sufficient for experimental models of asthma. The transcription factor NFAT plays a central role in cytokine transcriptional regulation in both cell types. Here, we analyze the molecular basis of IL13 gene transcription in Th2 and mast cells. We show that NFAT1 is the major NFAT protein involved in regulating IL13 transcription in mast cells. Although NFAT2 is correctly expressed and regulated in mast cells, it does not contribute to IL13 gene transcription as shown by analysis of cells lacking NFAT2 and cells expressing a constitutively active version of NFAT2. The difference between NFAT1 and NFAT2 appears to be due to a preferential synergistic interaction of NFAT1 with GATA proteins at the IL13 promoter. We suggest that mast cells lack a co-activator protein that stabilizes the binding of NFAT2 to the IL13 promoter by interacting either with NFAT2 itself or with a DNA-bound complex of NFAT2 and GATA proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229217     DOI: 10.1074/jbc.M406354200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?

Authors:  S I Said; S A Hamidi; L Gonzalez Bosc
Journal:  Eur Respir J       Date:  2010-04       Impact factor: 16.671

3.  IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.

Authors:  Matthew R Silver; Alexander Margulis; Nancy Wood; Samuel J Goldman; Marion Kasaian; Divya Chaudhary
Journal:  Inflamm Res       Date:  2009-09-18       Impact factor: 4.575

4.  Structural requirements for the inhibition of calcium mobilization and mast cell activation by the pyrazole derivative BTP2.

Authors:  Mankit Law; J Luis Morales; Laurie F Mottram; Archana Iyer; Blake R Peterson; Avery August
Journal:  Int J Biochem Cell Biol       Date:  2011-05-04       Impact factor: 5.085

5.  Dnmt3a restrains mast cell inflammatory responses.

Authors:  Cristina Leoni; Sara Montagner; Andrea Rinaldi; Francesco Bertoni; Sara Polletti; Chiara Balestrieri; Silvia Monticelli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

6.  The Tec family kinase, IL-2-inducible T cell kinase, differentially controls mast cell responses.

Authors:  Archana S Iyer; Avery August
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

7.  MicroRNA-221-222 regulate the cell cycle in mast cells.

Authors:  Ramon J Mayoral; Matthew E Pipkin; Mikhail Pachkov; Erik van Nimwegen; Anjana Rao; Silvia Monticelli
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway.

Authors:  Chia-Lin Hsu; Paul J Bryce
Journal:  J Immunol       Date:  2012-08-24       Impact factor: 5.422

9.  RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.

Authors:  Geetanjali Bansal; Jeffrey A DiVietro; Hye Sun Kuehn; Sudhir Rao; Karl H Nocka; Alasdair M Gilfillan; Kirk M Druey
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  The transcription factor Zeb2 regulates signaling in mast cells.

Authors:  Emilia Alina Barbu; Juan Zhang; Elsa H Berenstein; Jacqueline R Groves; Lauren M Parks; Reuben P Siraganian
Journal:  J Immunol       Date:  2012-05-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.